AKT1 and arthritic joint disease: Integrated bioinformatical analyses of multiple expression cohorts have revealed several hub genes, including AKT1, IL2, TP53, CD247, and CCL5, that commonly participate in the development of both OA and rheumatoid arthritis [9, 10]; these genes may act as therapeutic targets for arthritis therapy.